Ophthalmic Drugs Market is Growing at a Soulful CAGR of 5.1% During Forecast to 2025
Market Overview:
Increased level of research in the market is
expected to motivate the development of ophthalmic drugs. The expansion of the
pharmaceutical sector is expected to motivate the market at an incremental rate
in the coming years. Moreover, increased government backing is expected to
encourage the progress of the ophthalmic drug market in the approaching years.
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/5753
Reports
that review the pharmaceutical industry have been offered by Market Research
Future, which generates reports on industry verticals that evaluate the market
development and opportunities
Ophthalmic
Drugs Market Growth is expected to register 5.1% CAGR during the forecast period of 2019 to 2025 and held a
market value of USD 29.46 Billion in 2018.
.
Competitive
Analysis:
·
Valeant Pharmaceuticals International In
·
Teva Pharmaceutical Industries Ltd
·
Sun Pharmaceutical Industries Ltd
·
Shire plc
·
Santen Pharmaceutical Co
·
Regeneron Pharmaceuticals Inc
·
Pfizer Inc
·
Merck & Co
·
Genentech Inc
·
Bausch & Lomb Inc
·
Allergan plc
·
Actavis Generics
Segmentation:
·
The global ophthalmic drugs market is
segmented on the basis of indication, drug class, type of dosage, product, and
distribution channel.
·
On the basis of indication, the market is
classified as glaucoma, retinal disorders, inflammation/infection, dry eye,
allergies, uveitis, and others.
·
On the basis of drug class, the market is
classified as antiallergy, anti-VEGF agents, anti-inflammatory, antiglaucoma,
and others. The anti-inflammatory segment is further segmented into
nonsteroidal drugs and steroidal drugs.
·
On the basis of type of dosage, the market is
classified as eye drops, eye solutions, ointments, capsules and tablets, and
gels.
·
On the basis of the product, the market is
classified as prescription drugs and OTC drugs.
·
On the basis of the distribution channel, the
market is classified as hospital pharmacies, online pharmacies, drug stores,
and others.
Regional
Analysis:
The
Americas dominates the global ophthalmic drugs market and is likely to remain the
leading regional market over the forecast period due to the rising prevalence
of ophthalmic conditions and the high healthcare expenditure in the region.
Glaucoma accounts for up to 10 million visits to the physician in the U.S.,
leading to considerable expenses and demand for drugs. More than 120,000 in the
U.S. are blind because of glaucoma. These numbers are highly good news for the
ophthalmic drugs market in the Americas. The growing patient population
suffering from ophthalmic diseases is likely to drive the Americas market for
ophthalmic drugs over the forecast period. North America is likely to remain
the leading revenue generator in the global ophthalmic drugs market over the
forecast period.
Europe
is likely to hold on to the second place in the global ophthalmic drugs market
over the forecast period due to a similar set of reasons. The growing patient
population in Europe for ophthalmic diseases
Related Reports:
In-Vitro Diagnostics (IVD) Market
Research Report – Forecast to 2023
https://www.marketresearchfuture.com/infographics/in-vitro-diagnostics-market
Growth Hormone Market Research Report - Global Forecast till 2023
Comments
Post a Comment